Skip to main content
. 2020 Aug 16;472(10):1469–1480. doi: 10.1007/s00424-020-02443-9

Fig. 2.

Fig. 2

Effects of combined treatment of SNAP and SMN on the survival rate of INS-1 pancreatic cells. a Compared to other doses of SMN, 0.2 nM seemed to be the optimal dose for the survival of INS-1 pancreatic cells (n = 3, **P < 0.01, ***P < 0.001, ****P < 0.0001). b SNAP alone produced concentration-dependent reduction in survival rate compared with controls and SNAP combined SMN decreased the survival rate significantly compared with controls (****P < 0.0001; P values refer to differences between effects of SNAP and SNAP combined with SMN compared with controls). c SNAP produced a dose-dependent reduction in the survival rate of INS-1 pancreatic cells and this effect was significantly enhanced in the presence of SMN which reduced the survival rate in a concentration-dependent manner (n = 3, **P < 0.01, ***P < 0.001, ****P < 0.0001). P values refer to differences between the effects of SNAP alone and SNAP with SMN on the survival rate of INS-1 pancreatic cells. All values are expressed as ± SE. Abbreviations: INS-1, insulin-producing pancreatic cells; SMN, scopolamine methyl nitrate; SNAP, S-nitroso-N-acetylpenicillamine